The Supreme Court Today (May 7th) questioned the Central government’s directive to AYUSH authorities, asking why they were instructed not to act against misleading advertisements under Rule 170 of the Drugs and Cosmetics Rules, 1945. The inquiry came during a hearing of a plea filed by the Indian Medical Association (IMA) against an alleged smear campaign by Patanjali Ayurved and its founders Baba Ramdev and Acharya Balkrishna, targeting the COVID-19 vaccination drive and modern medicine.
